Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Accumulated Depreciation (2017 - 2025)

Historic Accumulated Depreciation for Perspective Therapeutics (CATX) over the last 13 years, with Q3 2025 value amounting to $5.2 million.

  • Perspective Therapeutics' Accumulated Depreciation rose 13047.91% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year increase of 13047.91%. This contributed to the annual value of $3.0 million for FY2024, which is 34245.14% up from last year.
  • Perspective Therapeutics' Accumulated Depreciation amounted to $5.2 million in Q3 2025, which was up 13047.91% from $4.4 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Accumulated Depreciation registered a high of $8.3 million during Q3 2023, and its lowest value of $15000.0 during Q4 2022.
  • In the last 5 years, Perspective Therapeutics' Accumulated Depreciation had a median value of $7.2 million in 2021 and averaged $5.1 million.
  • Its Accumulated Depreciation has fluctuated over the past 5 years, first plummeted by 9979.64% in 2022, then surged by 436000.0% in 2023.
  • Quarter analysis of 5 years shows Perspective Therapeutics' Accumulated Depreciation stood at $7.4 million in 2021, then plummeted by 99.8% to $15000.0 in 2022, then skyrocketed by 4360.0% to $669000.0 in 2023, then surged by 342.45% to $3.0 million in 2024, then skyrocketed by 75.51% to $5.2 million in 2025.
  • Its last three reported values are $5.2 million in Q3 2025, $4.4 million for Q2 2025, and $3.7 million during Q1 2025.